The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Julie - US: Multiple Autoimmune Disorders (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Julia takes LDN Low Dose naltrexone for thyroid nodules, frozen shoulder, MCTD, Lupus, Scleroderma, Sjogren's, degenerative disk disease, Dupuytren's Contracture, Multiple Chemical Sensitivity and more.
Erin - US: Hashimoto's, Lupus, Depression (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I’d to introduce Erin from the United States who takes LDN for hypopituitary or as it's sometimes called secondary adrenal insufficiency. Hashimoto's thyroiditis, lupus and depression. Thanks for joining me, Erin.
Dr Tom O’Bryan, LDN Radio Show 27 Sept 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Tom O'Bryan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dr Scott Zashin, LDN Radio Show 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Scott Zashin shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dr Scott Zashin, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Scott Zashin shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Rheumatologist Dr Scott Zashin talks about Pain conditions and LDN, he also answers callers questions.
Dr Ronald Hoffman Interviews Linda Elsegood on LDN and The LDN Book (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood shares her Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) Story on the Intelligent Medicine Podcast with Donald Hoffman.
Deanna Windham, DO - Lupus: A Misunderstood Disease (2017 Conference) (LDN, low dose naltrexone)
Dr Deanna Windham currently works in the Whisker Wellness Institute in California, the United States. She and her institute first heard of Low Dose Naltrexone (LDN) around 12 years ago while establishing their adjunctive cancer treatment program.